Operating Lease, Right-of-Use Asset in USD of ALX ONCOLOGY HOLDINGS INC from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ALX ONCOLOGY HOLDINGS INC quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2021 to Q3 2025.
  • ALX ONCOLOGY HOLDINGS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,306,000, a 69.2% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ALX ONCOLOGY HOLDINGS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,306,000 -$2,928,000 -69.2% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $1,453,000 -$2,989,000 -67.3% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $3,807,000 -$840,000 -18.1% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $4,023,000 -$824,000 -17% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $4,234,000 -$810,000 -16.1% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $4,442,000 -$796,000 -15.2% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $4,647,000 -$786,000 -14.5% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $4,847,000 -$779,000 -13.8% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $5,044,000 -$849,000 -14.4% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $5,238,000 -$845,000 -13.9% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $5,433,000 +$433,000 +8.66% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $5,626,000 +$3,797,000 +208% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $5,893,000 +$3,993,000 +210% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $6,083,000 +$3,983,000 +190% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $5,000,000 +$4,700,000 +1567% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $1,829,000 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $1,900,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $2,100,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $300,000 31 Mar 2021 10-Q 17 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.